Internal Medicine, Cardiovascular Disease · New Milford, CT
NPI
1982676862
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
11 Old Park Ln
New Milford, CT, 06776
Phone (860) 355-1149
Groups this clinician bills Medicare through
Medicare paid, 2024
$265K
3,827 services
Medicare patients, 2024
814
Average age 79
Drug cost, 2024
$1.4M
6,306 prescriptions
Company payments, 2025
$75.18
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Michael G Levine was code 99214 (office e&m - established), 1,320 times for 655 patients. In total Michael G Levine billed 3,827 services in 37 codes, and Medicare paid $265K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,320 | 655 | $95.86 | $127K |
| 93000 Electrocardiogram | Office | 425 | 401 | $11.01 | $4,679 |
| 85610 Clinical Chemistry | Office | 362 | 40 | $4.20 | $1,520 |
| 99211 Office E&M - Established | Office | 352 | 39 | $17.60 | $6,197 |
| 93306 Echocardiography (TTE/TEE) | Office | 260 | 255 | $161.28 | $42K |
| J2785 Injection, regadenoson, 0.1 mg | Office | 230 | 57 | $5.29 | $1,218 |
| A9500 Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 188 | 93 | $103.06 | $19K |
| 93294 External Electrocardiographic Monitoring | Office | 131 | 49 | $20.66 | $2,706 |
| 93296 External Electrocardiographic Monitoring | Office | 129 | 49 | $15.62 | $2,015 |
| 78452 Myocardial Perfusion Scan | Office | 95 | 94 | $375.32 | $36K |
| 93015 Electrocardiogram | Office | 76 | 75 | $54.46 | $4,139 |
| 93280 External Electrocardiographic Monitoring | Office | 54 | 37 | $63.13 | $3,409 |
| 99204 Office E&M - New | Office | 38 | 38 | $130.69 | $4,966 |
| 99223 Hospital E&M - Initial | Facility | 21 | 17 | $126.66 | $2,660 |
| 93225 Electrocardiogram | Office | 17 | 17 | $15.14 | $257 |
By year: 2022 $299K for 4,003 services; 2023 $274K for 3,726 services; 2024 $265K for 3,827 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 362 | 40 | $4.20 | $1,520 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael G Levine prescribed most often to Medicare patients was Eliquis (Apixaban), with 638 prescriptions and refills. In total Michael G Levine wrote 6,306 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 638 | 1,389 | 162 | $805K |
| Atorvastatin Calcium Generic | 605 | 1,746 | 191 | $7,105 |
| Metoprolol Succinate Generic | 598 | 1,707 | 192 | $8,836 |
| Losartan Potassium Generic | 389 | 1,127 | 117 | $3,507 |
| Furosemide Generic | 374 | 1,018 | 139 | $2,657 |
| Metoprolol Tartrate Generic | 350 | 966 | 114 | $2,626 |
| Amlodipine Besylate Generic | 332 | 963 | 109 | $2,322 |
| Lisinopril Generic | 265 | 775 | 86 | $2,042 |
| Xarelto Rivaroxaban | 238 | 544 | 58 | $302K |
| Carvedilol Generic | 187 | 544 | 58 | $1,349 |
| Rosuvastatin Calcium Generic | 174 | 513 | 59 | $2,207 |
| Warfarin Sodium Generic | 163 | 450 | 46 | $1,941 |
| Ezetimibe Generic | 147 | 438 | 51 | $3,303 |
| Hydrochlorothiazide Generic | 114 | 339 | 36 | $528 |
| Pravastatin Sodium Generic | 105 | 313 | 37 | $1,796 |
Brand drugs: 1,189 claims; generic drugs: 5,117 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael G Levine $75.18 ($75.18 in general payments such as food, travel and fees) from 2 companies. The largest payer was Exact Sciences Corporation with $50.73.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.